Purdue Pharma unveils $10bn opioid settlement plan to exit from bankruptcy

• Plan is backed by $4bn from Sackler family
• Most parties onboard but Democratic attorneys general oppose

Purdue Pharma is proposing a $10bn plan to emerge from bankruptcy that calls for it to be transformed into a company funnelling profits into the fight against the opioid crisis.

Those efforts would include a significant boost - more than $4bn - from members of the Sackler family who own the Connecticut-based pharmaceutical giant.